HD-OPM Archive
Topics › Statins

SAMSON N-of-1 trial: statin and placebo caused equal symptoms, pointing to nocebo

Louis Nervegna · Oct 15, 2025 · ♥ 7 reactions · 3 comments · original Facebook post
StatinsMyths, misinformation & controversies
↻ This is a repost. The main version (highest ranked) is N-of-1 trial: most statin side effects arose with placebo too, pointing to nocebo · Feb 24, 2025.
AI summary & key facts

Louis describes the NEJM N-of-1 trial in which patients who had stopped statins over side effects received four one-month bottles each of statin, placebo and nothing in random order. Symptoms were similar on placebo and statin but low with no bottle, and half of participants were able to restart statins. Louis concludes about 90% of side effects were nocebo.

On any given month, the participants were randomized to either a statin, a placebo, or nothing at all.

What happened is that participants reported very little side effects from taking nothing— but lots of side effects from taking either the placebo or the statin.

The only reasonable explanation for that is nocebo effect. In this study, 90% of the side effects were due to nocebo effect:

↪ Nocebo effect explained about 90% of symptoms in patients who quit statins (SAMSON trial)

The nocebo effect occurs when your mind creates physical symptoms in response to the thought that you are taking something (e.g. a pill or shot) that is somehow harming you. These physical symptoms are very real, but in the case of the nocebo effect, they are generated entirely by the mind. Not by the thing you are taking.

People who are prone to conspiratorial lines of thinking about medical topics are much more likely to experience nocebo effect. This is why you should always take testimonials from these people with a grain of salt:

facebook.com/share/r/1BPLbqjcwe

#noceboHD #statinsHD #nejmHD #samsonHD

Research cited

Patients who had discontinued statins because of side effects received four one-month bottles of a statin, four bottles of placebo, and four empty bottles, randomly sequenced, each to be used for 1 month. Symptom burden with placebo was not significantly different to the symptom burden with the statin, and half the study participants were able to successfully restart statins.

← newer: Most negative anecdotes about standard treatments may be nocolder: 2025 US blood pressure guideline: 57% of men and 53% of wome →